Boothbay Fund Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $41K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $557K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $233K | Sell |
|
|||||
|
2021
Q2 | $274K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $395K | Sell |
|
|||||
|
2020
Q2 | $468K | Sell |
|
|||||
|
2020
Q1 | $354K | Sell |
|
|||||
|
2019
Q4 | $701K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $335K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|